Holen Sie sich die Stockscreener-App
149.21
0.53%
-0.84
Schlusskurs vom Vortag:
$150.05
Offen:
$148.43
24-Stunden-Volumen:
86,970
Relative Volume:
0.19
Marktkapitalisierung:
$4.40B
Einnahmen:
$802.80M
Nettoeinkommen (Verlust:
$53.51M
KGV:
86.25
EPS:
1.73
Netto-Cashflow:
$91.12M
1W Leistung:
-4.22%
1M Leistung:
+3.14%
6M Leistung:
-19.84%
1J Leistung:
-2.05%
1-Tages-Spanne:
$148.30
$149.71
1-Wochen-Bereich:
$147.06
$156.81
52-Wochen-Spanne:
$123.00
$225.00
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Vergleichen Sie INSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
149.29 | 4.71B | 802.80M | 53.51M | 91.12M | 1.73 |
|
ABT
Abbott Laboratories
|
134.54 | 224.53B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.03 | 152.31B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
385.47 | 148.10B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.42 | 109.16B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.15 | 44.29B | 5.54B | 4.18B | 623.10M | 7.00 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Watch Inspire Medical CEO on Improving Patient Outcomes - Bloomberg.com
Transcript : Inspire Medical Systems, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 11 - marketscreener.com
3 Healthcare Stocks to Keep an Eye On - Yahoo Finance
Inspire Medical Systems, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 20, 2024 to Discuss Your RightsINSP - ACCESS Newswire
Lost Money on Inspire Medical Systems, Inc.(INSP)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Notifies Inspire Medical Systems, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – INSP - ACCESS Newswire
Inspire Medical Systems, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationINSP - ACCESS Newswire
Investors Who Lost Money on Inspire Medical Systems, Inc. (INSP) Should Contact Levi & Korsinsky About Pending Class Action – INSP - ACCESS Newswire
Leerink Partnrs Has Pessimistic View of INSP Q2 Earnings - Defense World
Inspire medical systems outlines full launch of Inspire V with 17%-19% 2025 revenue growth target - MSN
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance
Inspire Medical Systems, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - Yahoo Finance
Q3 Earnings Forecast for INSP Issued By Leerink Partnrs - Defense World
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts - MSN
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy - Yahoo Finance
Inspire Medical Systems (INSP) Target Price Lowered by Morgan St - GuruFocus
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know - Yahoo Finance
Inspire Medical Systems (INSP) Receives a Buy from Lake Street - The Globe and Mail
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2025 Earnings Call Transcript - Insider Monkey
Inspire Medical Systems (NYSE:INSP) Shares Gap Down After Insider Selling - Defense World
Inspire Medical Systems (NYSE:INSP) & TELA Bio (NASDAQ:TELA) Critical Analysis - Defense World
Breaking Down Inspire Medical Systems: 13 Analysts Share Their Views - Benzinga
INSP's Q1 Revenue Surpasses Expectations with Strong Growth | IN - GuruFocus
Inspire Medical to fully launch next-gen system in U.S. this month - MassDevice
JP Morgan Maintains Overweight Rating, Lowers PT for Inspire Med - GuruFocus
Inspire Medical Systems (INSP) Target Price Lowered by Morgan Stanley | INSP Stock News - GuruFocus
JP Morgan Maintains Overweight Rating, Lowers PT for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus
Inspire Medical Systems (INSP) Price Target Lowered by Wells Fargo | INSP Stock News - GuruFocus
Inspire Medical (INSP) Faces Price Target Reduction Amid Mid-Yea - GuruFocus
Inspire Medical (INSP): Morgan Stanley Updates Price Target Amid - GuruFocus
Inspire Medical (INSP): Morgan Stanley Updates Price Target Amidst Positive Outlook | INSP Stock News - GuruFocus
Inspire Medical Systems (INSP) Target Price Raised by Baird | IN - GuruFocus
Inspire Medical Systems (INSP) Target Price Raised by Baird | INSP Stock News - GuruFocus
Inspire Medical (INSP) Price Target Increased by Baird | INSP St - GuruFocus
Inspire Medical (INSP) Price Target Increased by Baird | INSP Stock News - GuruFocus
Morgan Stanley Cuts Price Target on Inspire Medical Systems to $200 From $220, Keeps Overweight Rating - marketscreener.com
Inspire Medical Systems’ revenue up 23% to USD 201.3M in Q1 2025 - Medical Buyer
Inspire Medical (INSP) Faces Price Target Reduction Amid Mid-Year Challenges | INSP Stock News - GuruFocus
Inspire Medical Systems Inc (INSP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Inspire Medical Systems beats Q1 estimates, raises EPS outlook - Investing.com Australia
Decoding Inspire Medical Systems Inc (INSP): A Strategic SWOT In - GuruFocus
Inspire Medical Systems Reports Strong Q1 2025 Growth - TipRanks
Inspire: Q1 Earnings Snapshot - MySA
Inspire Medical Systems Q1 2025 Earnings Call Transcript - MarketBeat
Inspire Medical Systems (INSP) Reports Strong Q1 Growth and Key Developments - GuruFocus
Inspire Medical Systems earnings beat by $0.34, revenue topped estimates - Investing.com Canada
Earnings call transcript: Inspire Medical Systems beats Q1 2025 EPS expectations - Investing.com Nigeria
Inspire medical systems director Shawn McCormick sells $57,600 in stock By Investing.com - Investing.com India
Inspire medical systems director Shawn McCormick sells $57,600 in stock - Investing.com
Inspire Medical Systems Q1 2025 slides: Revenue up 23% as Inspire V launch approaches By Investing.com - Investing.com South Africa
Inspire Medical Systems beats Q1 estimates, raises EPS outlook By Investing.com - Investing.com Nigeria
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):